Biogen receives FDA approval for breakthrough ALS treatment: 'Pivotal moment in ALS research'
BOSTON - Cambridge, Massachusetts-based Biogen has gotten the green light for a breakthrough ALS treatment that targets a devastating, ultra-rare genetic form of the progressive ne…
